|
|
|
|
Q32 Bio Inc (NASDAQ: QTTB) |
|
|
|
| |
Q32 Bio Inc Accounts Receivables Turnover Ratio from the third quarter 2026 to the third quarter 2025
Quarterly Results, Trends, Rankings, Statistics
Q32 Bio Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2026 to a ratio of 113.13, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the third quarter 2026. Q32 Bio Inc 's Accounts Receivable average collection period in the Sep 30 2026 quarter, | |